Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Neuro-Oncology|September 24, 2010
Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cellsJun Sunayama, Atsushi Sato, Ken-ichiro Matsuda, et al.
Neuro-Oncology Advances|November 2, 2020
<i>TERT</i> promoter mutation associated with multifocal phenotype and poor prognosis in patients with <i>IDH</i> wild-type glioblastomaZensho Kikuchi, Ichiyo Shibahara, Tetsu Yamaki, et al.
Stem Cells (Dayton, Ohio)|July 28, 2011
FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicityJun Sunayama, Atsushi Sato, Ken-Ichiro Matsuda, et al.
Clinical and Experimental Nephrology|July 23, 2015
Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST)Osamu Saito, Eiji Kusano, Tetsu Akimoto, et al.
Journal of Neuro-Oncology|June 5, 2024
Clinical and molecular features of patients with IDH1 wild-type primary glioblastoma presenting unexpected short-term survival after gross total resectionMariko Toyoda, Ichiyo Shibahara, Ryota Shigeeda, et al.
Journal of Neuro-Oncology|May 24, 2017
Opening the ventricle during surgery diminishes survival among patients with newly diagnosed glioblastoma treated with carmustine wafers: a multi-center retrospective studyYukihiko Sonoda, Ichiyo Shibahara, Ken-Ichiro Matsuda, et al.
Community Genetics|June 19, 2007
Community engagement and informed consent in the International HapMap projectCharles Rotimi, Mark Leppert, Ichiro Matsuda, et al.
Neuro-Oncology Advances|August 6, 2021
Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging-A controversyMasayuki Kanamori, Hirokazu Takami, Tomonari Suzuki, et al.
Neuro-Oncology|August 21, 2020
So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?Masayuki Kanamori, Hirokazu Takami, Shigeru Yamaguchi, et al.
Acta Neuropathologica Communications|November 24, 2020
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutationsHideyuki Arita, Yuko Matsushita, Ryunosuke Machida, et al.
Pageof 4